UB Paderborn / Katalog / Suche / in CDI

Binding of Cyclic Diguanylate in the Non-catalytic EAL Domain of FimX Induces a Long-range Conformational Change

The Journal of biological chemistry, 2011-01, Vol.286 (4), p.2910-2917

2011

Volltextzugriff (PDF)

Exploration of Target Spaces in the Human Genome for Protein and Peptide Drugs

Genomics, proteomics & bioinformatics, 2022-08, Vol.20 (4), p.780-794

2022

Volltextzugriff (PDF)

Functional Divergence of FimX in PilZ Binding and Type IV Pilus Regulation

Journal of Bacteriology, 2012-11, Vol.194 (21), p.5922-5931

2012

Volltextzugriff (PDF)

CTR-DB, an omnibus for patient-derived gene expression signatures correlated with cancer drug response

Nucleic acids research, 2022-01, Vol.50 (D1), p.D1184

2022

Volltextzugriff (PDF)

CDS-DB, an omnibus for patient-derived gene expression signatures induced by cancer treatment

Nucleic acids research, 2024-01, Vol.52 (D1), p.D1163

2024

Volltextzugriff (PDF)

2′,3′-cAMP hydrolysis by metal-dependent phosphodiesterases containing DHH, EAL, and HD domains is non-specific: Implications for PDE screening

Biochemical and biophysical research communications, 2010-07, Vol.398 (3), p.500-505

2010

Volltextzugriff (PDF)

Model‐Informed Drug Development: Current US Regulatory Practice and Future Considerations

Clinical pharmacology and therapeutics, 2019-04, Vol.105 (4), p.899-911

2019

Volltextzugriff (PDF)

Serum ATX as a novel biomarker for breast cancer

Medicine (Baltimore), 2019-03, Vol.98 (13), p.e14973-e14973

2019

Volltextzugriff (PDF)

Long short-term memory recurrent neural network for pharmacokinetic-pharmacodynamic modeling

International journal of clinical pharmacology and therapeutics, 2021-02, Vol.59 (2), p.138

2021

Volltextzugriff (PDF)

Connecting Hydroxychloroquine In Vitro Antiviral Activity to In Vivo Concentration for Prediction of Antiviral Effect: A Critical Step in Treating Patients With Coronavirus Disease 2019

Clinical infectious diseases, 2020-12, Vol.71 (12), p.3232-3236

2020

Volltextzugriff (PDF)

Clinicopathological characteristics and value of HER2-low expression evolution in breast cancer receiving neoadjuvant chemotherapy

Breast (Edinburgh), 2024-02, Vol.73, p.103666-103666, Article 103666

2024

Volltextzugriff (PDF)

TJP3 promotes T cell immunity escape and chemoresistance in breast cancer: a comprehensive analysis of anoikis-based prognosis prediction and drug sensitivity stratification

Aging (Albany, NY.), 2023-11, Vol.15 (22), p.12890-12906

2023

Volltextzugriff (PDF)

Preoperative Radiotherapy Does Not Change the Existing Treatment Paradigm in Stage III Breast Cancer

Oncology, 2024, Vol.102 (4), p.310

2024

Volltextzugriff (PDF)

Relationships between SNPs and prognosis of breast cancer and pathogenic mechanism

Molecular genetics & genomic medicine, 2019-09, Vol.7 (9), p.e871-n/a

2019

Volltextzugriff (PDF)

Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies

Cell research, 2021-05, Vol.31 (5), p.517-525

2021

Volltextzugriff (PDF)

Proceedings of a Workshop: Precision Dosing: Defining the Need and Approaches to Deliver Individualized Drug Dosing in the Real‐World Setting

Clinical pharmacology and therapeutics, 2021-01, Vol.109 (1), p.25-28

2021

Volltextzugriff (PDF)

Recommendations for Dose Selection for Adolescent Patients in Relevant Adult Oncology Clinical Trials

Clinical pharmacology and therapeutics, 2022-04, Vol.111 (4), p.956-963

2022

Volltextzugriff (PDF)

Relationship between five GWAS-identified single nucleotide polymorphisms and female breast cancer in the Chinese Han population

Tumor biology, 2016-07, Vol.37 (7), p.9739-9744

2016

Volltextzugriff (PDF)

Thiamine-modified metabolic reprogramming of human pluripotent stem cell-derived cardiomyocyte under space microgravity

Signal transduction and targeted therapy, 2024-04, Vol.9 (1), p.86-86, Article 86

2024

Volltextzugriff (PDF)

FDA Approval: Uridine Triacetate for the Treatment of Patients Following Fluorouracil or Capecitabine Overdose or Exhibiting Early-Onset Severe Toxicities Following Administration of These Drugs

Clinical cancer research, 2016-09, Vol.22 (18), p.4545-4549

2016

Volltextzugriff (PDF)

The Association Between Baseline Hepatic or Renal Function and Clinical Outcomes for Patients With Non‐Small Cell Lung Cancer Treated With a PD‐1/PD‐L1 Blocking Antibody Using Real‐World and Trial Data

Clinical pharmacology and therapeutics, 2023-05, Vol.113 (5), p.1139-1149

2023

Volltextzugriff (PDF)

U.S. Food and Drug Administration Approval: Cabozantinib for the Treatment of Advanced Renal Cell Carcinoma

Clinical cancer research, 2017-01, Vol.23 (2), p.330-335

2017

Volltextzugriff (PDF)

Bridging Adult Experience to Pediatrics in Oncology Drug Development

Journal of clinical pharmacology, 2017-10, Vol.57 (S10), p.S129-S135

2017

Volltextzugriff (PDF)

Gold Nanourchins Improve Virus Targeting and Plasmonic Coupling for Virus Diagnosis on a Smartphone Platform

ACS sensors, 2022-12, Vol.7 (12), p.3741-3752

2022

Volltextzugriff (PDF)

Screening of the miRNAs related to breast cancer and identification of its target genes

European journal of gynaecological oncology, 2014, Vol.35 (6), p.696-700

2014

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Binding of Cyclic Diguanylate in the Non-catalytic EAL Domain of FimX Induces a Long-range Conformational Change

Exploration of Target Spaces in the Human Genome for Protein and Peptide Drugs

Functional Divergence of FimX in PilZ Binding and Type IV Pilus Regulation

CTR-DB, an omnibus for patient-derived gene expression signatures correlated with cancer drug response

CDS-DB, an omnibus for patient-derived gene expression signatures induced by cancer treatment

2′,3′-cAMP hydrolysis by metal-dependent phosphodiesterases containing DHH, EAL, and HD domains is non-specific: Implications for PDE screening

Model‐Informed Drug Development: Current US Regulatory Practice and Future Considerations

Serum ATX as a novel biomarker for breast cancer

Long short-term memory recurrent neural network for pharmacokinetic-pharmacodynamic modeling

Connecting Hydroxychloroquine In Vitro Antiviral Activity to In Vivo Concentration for Prediction of Antiviral Effect: A Critical Step in Treating Patients With Coronavirus Disease 2019

Clinicopathological characteristics and value of HER2-low expression evolution in breast cancer receiving neoadjuvant chemotherapy

TJP3 promotes T cell immunity escape and chemoresistance in breast cancer: a comprehensive analysis of anoikis-based prognosis prediction and drug sensitivity stratification

Preoperative Radiotherapy Does Not Change the Existing Treatment Paradigm in Stage III Breast Cancer

Relationships between SNPs and prognosis of breast cancer and pathogenic mechanism

Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies

Proceedings of a Workshop: Precision Dosing: Defining the Need and Approaches to Deliver Individualized Drug Dosing in the Real‐World Setting

Recommendations for Dose Selection for Adolescent Patients in Relevant Adult Oncology Clinical Trials

Relationship between five GWAS-identified single nucleotide polymorphisms and female breast cancer in the Chinese Han population

Thiamine-modified metabolic reprogramming of human pluripotent stem cell-derived cardiomyocyte under space microgravity

FDA Approval: Uridine Triacetate for the Treatment of Patients Following Fluorouracil or Capecitabine Overdose or Exhibiting Early-Onset Severe Toxicities Following Administration of These Drugs

The Association Between Baseline Hepatic or Renal Function and Clinical Outcomes for Patients With Non‐Small Cell Lung Cancer Treated With a PD‐1/PD‐L1 Blocking Antibody Using Real‐World and Trial Data

U.S. Food and Drug Administration Approval: Cabozantinib for the Treatment of Advanced Renal Cell Carcinoma

Bridging Adult Experience to Pediatrics in Oncology Drug Development

Gold Nanourchins Improve Virus Targeting and Plasmonic Coupling for Virus Diagnosis on a Smartphone Platform

Screening of the miRNAs related to breast cancer and identification of its target genes

Aktive Filter

Suchergebnisse filtern